Skip to main content

Cesarean Section

5
Pipeline Programs
8
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Combined Therapeutics
2 programs
1
Tranexamic AcidPhase 41 trial
Sugar free chew gumN/A1 trial
Active Trials
NCT06952985Completed60Est. Oct 2024
NCT07013812Completed68Est. Apr 2024
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
1
Detection of sufentanil concentrationPhase 41 trial
Active Trials
NCT03764202Completed100Est. Dec 2017
Nordic Pharma
Nordic PharmaFrance - Paris
1 program
1
2% chlorhexidine gluconate clothPhase 21 trial
Active Trials
NCT03423147Terminated319Est. Feb 2021
Stryker
StrykerCA - San Jose
1 program
1
2% chlorhexidine gluconate clothPhase 2
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
Preservative free 1% ChloroprocainePhase 11 trial
Active Trials
NCT03760718Completed15Est. Dec 2021
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Closure of uterine incision at C sectionN/A1 trial
Active Trials
NCT02288013Completed100Est. Dec 2014
Sunshine Biopharma
Sunshine BiopharmaQC - Varennes
1 program
Intrathecal morphine as well as local anaesthetic in BlocksN/A1 trial
Active Trials
NCT03267628Withdrawn0Est. Dec 2019
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Use of Cesarean Birth at Private Health Facilities in Lilongwe and Blantyre, MalawiN/A1 trial
Active Trials
NCT04442997Completed260Est. Jun 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Combined TherapeuticsTranexamic Acid
UNION therapeuticsDetection of sufentanil concentration
Nordic Pharma2% chlorhexidine gluconate cloth
Oregon TherapeuticsPreservative free 1% Chloroprocaine
Combined TherapeuticsSugar free chew gum
Colorado TherapeuticsUse of Cesarean Birth at Private Health Facilities in Lilongwe and Blantyre, Malawi
Sunshine BiopharmaIntrathecal morphine as well as local anaesthetic in Blocks
Johnson & JohnsonClosure of uterine incision at C section

Clinical Trials (8)

Total enrollment: 922 patients across 8 trials

NCT07013812Combined TherapeuticsTranexamic Acid

Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section

Start: Nov 2023Est. completion: Apr 202468 patients
Phase 4Completed
NCT03764202UNION therapeuticsDetection of sufentanil concentration

Determination of Sufentanil in Breast Milk of Puerpera

Start: Aug 2015Est. completion: Dec 2017100 patients
Phase 4Completed
NCT03423147Nordic Pharma2% chlorhexidine gluconate cloth

Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor

Start: Oct 2018Est. completion: Feb 2021319 patients
Phase 2Terminated
NCT03760718Oregon TherapeuticsPreservative free 1% Chloroprocaine

Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery

Start: Sep 2019Est. completion: Dec 202115 patients
Phase 1Completed
NCT06952985Combined TherapeuticsSugar free chew gum

Role of Gum Chewing in Post-operative Gut Motility After Cesarean Section

Start: May 2024Est. completion: Oct 202460 patients
N/ACompleted
NCT04442997Colorado TherapeuticsUse of Cesarean Birth at Private Health Facilities in Lilongwe and Blantyre, Malawi

Use of Cesarean Birth at Private Health Facilities in Lilongwe and Blantyre, Malawi

Start: Feb 2022Est. completion: Jun 2022260 patients
N/ACompleted
NCT03267628Sunshine BiopharmaIntrathecal morphine as well as local anaesthetic in Blocks

Comparison of Intrathecal Morphine With the Quadratus Lumborum Type 2 Block for Post-operative Analgesia Following Elective Caesarean Section (QLBvITM Study)

Start: Jan 2019Est. completion: Dec 20190
N/AWithdrawn
NCT02288013Johnson & JohnsonClosure of uterine incision at C section

Uterine Closure at C-section by Stratafix Tissue Control Device: Randomized Case-Control Study

Start: Oct 2013Est. completion: Dec 2014100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.